InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the detailed record of transactions filed by Beier David W, 董事. Director active across 1 company, notably Infinity Pharmaceuticals, INC.. In total, 1 filings have been published. Activity tracked since 10 June 2021. The latest transaction was disclosed on 10 June 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Beier David W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报1 总计
3,061 股@ US$3.43100.0% 占其流量Common StockSEC:0001140361-21-020650:0
1 条申报中的 1 条
About Beier David W
David W. Beier is a Director at Infinity Pharmaceuticals, Inc., a biopharmaceutical company focused on developing cancer treatments. As a board member, he plays a key role in the governance of the company, bringing his expertise in the biopharmaceutical field to help guide strategic decisions.
